- Symbol
- FBIOP
- Segment MIC
- XNCM
- ISIN
- US34960Q2084
- Trading currency
- USD
XNCM:FBIOP — listed on NASDAQ CAPITAL MARKET
Fortress Biotech, Inc. is a biopharmaceutical company focused on developing and commercializing pharmaceutical products and product candidates. The company operates through subsidiaries, including Cyprium Therapeutics and Journey Medical Corporation, and has a pipeline that includes both commercial-stage products and development-stage candidates across various therapeutic areas such as oncology, neurology, and rare diseases. Fortress Biotech generates revenue through product sales, royalties, and partnerships, serving a diverse range of patients in need of novel therapies.